Delivery Order SPE2DR25D3103-SPE2DR26F9R09
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,055.09 to AmerisourceBergen Drug Corp for Annovera vaginal rings under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by December 8, 2025. This award represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio and will be fulfilled from the company's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $4,323.44 to AmerisourceBergen Drug Corp for Annovera vaginal rings on March 11, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of March 12, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's medical supply chain....
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for Annovera vaginal rings, with a ceiling value of $6,710.26. This competitively awarded, firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of August 12, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order totaling $1,377.53 to AmerisourceBergen Drug Corp for Annovera vaginal rings on June 2, 2025, with completion expected by June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,373.73 to AmerisourceBergen Drug Corp for Annovera vaginal rings on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania. Annovera is a long-acting contraceptive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,218.26 for Annovera vaginal rings on December 11, 2025, with completion expected by December 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,978.92 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings under a firm fixed-price contract. The award was made on December 4, 2025, with an ultimate completion date of December 5, 2025, and represents a non-set-aside, competitively awarded delivery order. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,756.07 for Annovera vaginal rings under a firm fixed price contract. This non-set-aside delivery order was executed on December 3, 2025, with an ultimate completion date of December 4, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency awarded a $2,570.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for Annovera vaginal rings on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-set-aside competitive award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's Corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,959.80 to AmerisourceBergen Drug Corp for Annovera vaginal rings on May 8, 2025, with completion scheduled for May 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this requirement as a...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9R09Delivery Order
The Defense Logistics Agency awarded a $4,176.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Annovera vaginal rings on December 18, 2025, with a completion date of December 19, 2025. This non-set-aside contract represents a small-value transaction executed through AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award specifies performance at the contractor's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical prime vendor agreement running through December 2026. As a child contract under this comprehensive IDC vehicle, the Annovera order exemplifies the company's role as a critical supplier of specialized pharmaceutical products to military healthcare systems. AmerisourceBergen's federal procurement portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains, positioning the company as a primary pharmaceutical distributor for Defense Health Agency and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 12/17/25 |